November 2020 Bonus ASH Annual Meeting Preview Edition (Volume 6, Issue 14)

November 2020 Bonus ASH Annual Meeting Preview Edition

Volume 6, Issue 14

This issue offers a behind-the-scenes look at this year’s virtual annual meeting, and more.

Table of Contents

November 2020 Bonus Issue

Editor’s Corner: Learning to Lead

Monday, November 16th, 2020
We learn a lot in medical school. But as I move through my still-early career, I find myself occasionally reflecting on what we are...

November 2020 Bonus Issue

IMGN632 Receives Breakthrough Therapy Designation for BPDCN

Monday, November 16th, 2020
The FDA has granted breakthrough therapy designation to IMGN632, a CD123-targeting antibody drug conjugate, for the treatment of patients with relapsed or refractory blastic...
The Society Pages

Kwaku Ohene-Frempong Wins Assistant Secretary of Health Exceptional Service Medal, ASH Members Elected to...

Monday, November 16th, 2020
Kwaku Ohene-Frempong Wins Assistant Secretary of Health Exceptional Service Medal  U.S. Assistant Secretary for Health Adm. Brett P. Giroir, MD, recently presented American Society of Hematology...

FDA Clears Scopio Labs’ Full Field Peripheral Blood Smear System

Monday, November 16th, 2020
The FDA has granted clearance to Scopio Labs’ X100 Full Field Peripheral Blood Smear (Full Field PBS) application for use with in vitro hematology...

NIH Awards $1.5M to Study rHEALTH’s Fingerstick Hemophilia Test

Monday, November 16th, 2020
The National Institutes of Health (NIH) has awarded $1.5 million to continue development of diagnostic company rHEALTH’s fingerstick blood test for monitoring factor VIII...

Venetoclax Combination Granted Full Approval for Newly Diagnosed AML

Monday, November 16th, 2020
Venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine (LDAC) has been approved for the treatment of adults with newly diagnosed acute myeloid leukemia...

FDA Issues Stricter Guidelines for Coronavirus Vaccine Developers

Monday, November 16th, 2020
The FDA recently released stricter guidelines for the development of a coronavirus vaccine, calling on developers to provide comprehensive safety data from clinical trials...

November 2020 Bonus Issue

On location

Take Note: Virtual Format Provides Access to Thousands of High-Quality Abstracts

Monday, November 16th, 2020
ASH Secretary Robert Brodsky, MD, from Johns Hopkins University School of Medicine, has been involved with the ASH Annual Meeting for years. In 2017,...

When Virtual Becomes the Reality

Monday, November 16th, 2020
A behind-the-scenes look at how the American Society of Hematology reworked its annual meeting for the virtual setting Preparations for the 62nd American Society of...
On location

2020 ASH Annual Meeting Preview: Conversations With Co-Chairs

Monday, November 16th, 2020
Education Program Co-chairs Scientific Program Co-chairs How are speakers being asked to modify their presentations for a virtual format? Leslie Kean, MD, PhD: Even in this new...
On location

Rare Conditions of Great Importance in Differential Diagnoses

Monday, November 16th, 2020
Hematologists are confronted by an array of complex and somewhat obscure conditions. As a follow-up to a popular session at the 2018 ASH Annual...
On location

Balancing the Yin and Yang of Autoimmunity and Immunodeficiencies

Monday, November 16th, 2020
As part of this year’s Education Program, experts will lead a case-based discussion of the diagnosis, clinical spectrum, and treatment options for patients with...
On location

Challenges With TCRs, CAR T Cells, and Other Cell Therapies

Monday, November 16th, 2020
As indications for allogeneic hematopoietic cell transplantation (HCT) and adoptive cellular therapies are expanding, more patients are benefiting from these approaches. However, clinicians are...
On location

Battling Burnout: Big Ideas From Hematology Trainees

Monday, November 16th, 2020
During this year’s Special Symposium on Quality, experts will discuss an often-overlooked driver of quality of patient care: burnout. Attendees will get a chance...
On location

In AML, More Options Lead to More Questions

Monday, November 16th, 2020
Until recently, treatment options for patients with acute myeloid leukemia (AML) were limited to cytotoxic chemotherapeutic agents, but the past few years have seen...
On location

The Expanding Immunotherapy Arsenal in Myeloma

Monday, November 16th, 2020
The treatment of multiple myeloma (MM) in 2020 includes at least seven different therapeutic classes: corticosteroids, conventional chemotherapy, immunomodulatory agents, proteasome inhibitors, deacetylase inhibitors,...
On location

Blood and Beyond: Medical Mistakes and Miracles

Monday, November 16th, 2020
This year’s Blood and Beyond session will be hosted by the editors of Blood and will showcase the personal journey of Robert K. Massie...
On location

Single-Cell Analysis: Understanding Myeloid Malignancies and Disease Risk

Monday, November 16th, 2020
Over the past several years, there have been major advances in the use of single cell analysis in understanding hematopoietic development and hematologic diseases....